NeuroPace Stock (NASDAQ: NPCE) stock price, news, charts, stock research, profile.
You can purchase shares of NeuroPace (NASDAQ:NPCE) through any online brokerage.
Other companies in NeuroPace’s space includes: Semler Scientific (NASDAQ:SMLR), Baird Medical Investment (NASDAQ:BDMD), Varex Imaging (NASDAQ:VREX), AngioDynamics (NASDAQ:ANGO) and BrainsWay (NASDAQ:BWAY).
NeuroPace has a consensus price target of $14.90.
The stock price for NeuroPace (NASDAQ: NPCE) is $13.75 last updated January 21, 2025 at 6:56 PM EST.
There are no upcoming dividends for NeuroPace.
NeuroPace’s Q4 earnings are confirmed for Tuesday, March 4, 2025.
There is no upcoming split for NeuroPace.
NeuroPace is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.